Insider · CIK 0001750085
Marianne Zhen
officer
Files at INVA (Innoviva, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2025 | INVA Innoviva, Inc. | FTax withholding Common Stock | -992 | $18.78 | $19k | 50,320 | May 22, 2025 |
| Feb 24, 2025 | INVA Innoviva, Inc. | AGrant or award Common Stock | +8,938 | $18.08 | $162k | 51,312 | Mar 26, 2025 |
| Feb 24, 2025 | INVA Innoviva, Inc. | AGrant or award Non-statutory Stock Optionderivative | +30,300 | $0.00 | $0 | 93,322 | Mar 26, 2025 |
| Feb 20, 2025 | INVA Innoviva, Inc. | FTax withholding Common Stock | -2,565 | $18.07 | $46k | 42,374 | Feb 24, 2025 |
| Nov 15, 2024 | INVA Innoviva, Inc. | AGrant or award Common Stock | +300 | $0.00 | $0 | 45,915 | Nov 22, 2024 |
| Nov 20, 2024 | INVA Innoviva, Inc. | FTax withholding Common Stock | -976 | $19.15 | $19k | 44,939 | Nov 22, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.